Evaluating novel COVID-19 vaccines in the current chapter of the pandemic.

GeurtsvanKessel, Corine H; de Vries, Rory D

GeurtsvanKessel, Corine H; de Vries, Rory D.

GeurtsvanKessel CH; Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, Netherlands.
de Vries RD; Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, Netherlands. Electronic address: r.d.devries@erasmusmc.nl.

Lancet Infect Dis ; 22(12): 1652-1654, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2008207

Subject(s)

COVID-19; Influenza Vaccines; Influenza, Human; Vaccines; Humans; Pandemics/prevention & control; COVID-19 Vaccines; COVID-19/prevention & control; Influenza, Human/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Vaccines / Influenza, Human / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(22)00517-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google